Recalls / Active ingredient / Gemcitabine Hydrochloride
Gemcitabine Hydrochloride
1 FDA drug recall involving the active ingredient “Gemcitabine Hydrochloride”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-15 | Class II | GEMCITABINE INJECTION 200MG/5.26ML; NDC/UPC 72485-221-02; RX; SINGLEDOSE VIAL | Cardinal Health Inc. |